Merck Revenues Increase by 2.7% to € 1.9 Billion

Merck KGaA announced today that Group total revenues rose 2.7% in the third quarter to € 1,944 million from € 1,893 million in the year-ago quarter as the Pharmaceuticals divisions continued to grow and the Chemicals divisions continued to recover from the economic crisis. Royalty income, declined 9.7% to € 82 million. Mainly due to inventory adjustments and, underutilization of capacities, the gross margin was little changed compared to the year-ago quarter at € 1,422 million. Lees verder